Cell Tissue Culture Supplies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global cell tissue culture supplies market is on a robust growth trajectory, projected to grow at a CAGR of 10.09% between 2023 and 2032. According to industry insights, the market is expected ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global cell tissue culture supplies market is on a robust growth trajectory, projected to grow at a CAGR of 10.09% between 2023 and 2032. According to industry insights, the market is expected to reach USD 19.7 Billion by 2025, and continue expanding to a valuation of approximately USD 38.6 Billion by the end of 2032. This surge is driven by increased demand for biopharmaceuticals, advances in regenerative medicine, and the rising prevalence of chronic illnesses.Market Insights The market is being shaped by the growing need for effective, scalable cell culture technologies, particularly as the biopharmaceutical sector continues to grow rapidly. The cell tissue culture supplies market plays a critical role in enabling drug discovery, development, and the manufacturing of biologics, including monoclonal antibodies and vaccines. The historic growth in this sector has been marked by continuous innovation in cell culture technologies, particularly the development of serum-free, chemically defined media, and the shift towards single-use systems in manufacturing. With the introduction of advanced cell culture systems and increasing investments in R&D, the market has become a hub of innovation and scientific advancement. Drivers of Growth Several key factors are fueling the demand for cell tissue culture supplies: • Biopharmaceutical Expansion: Increased development of protein-based therapeutics and biosimilars is creating strong demand for scalable and cost-effective culture media and reagents. • Rise in Regenerative Medicine and Tissue Engineering: Advancements in lab-generated tissues, including ligaments, cartilage, and blood vessels, are propelling the need for specialized culture supplies. • Increased Clinical Trials: An increasing number of drug candidates entering clinical trials requires optimized cell culture solutions for preclinical and toxicological evaluations. • Personalized Medicine Trends: The growing shift towards customized therapeutic approaches is increasing the need for precise, serum-free culture environments. Business Opportunity The introduction of cost-effective cell culture media, especially serum-free and chemically defined options, represents a significant opportunity for market players. Contract manufacturing organizations (CMOs) are increasingly relying on these media types for consistent batch-to-batch performance and scalable production, particularly in biologics manufacturing. Additionally, rising interest in in vitro diagnostics and the use of tissue culture technologies in vaccine production—especially for emerging infectious diseases—presents further opportunities for stakeholders in this market. The demand for monoclonal antibodies in immunotherapies is also anticipated to sustain the market’s long-term potential. Regional Analysis • United States: The U.S. continues to dominate the global market with the presence of leading biopharmaceutical companies, robust R&D infrastructure, and increasing focus on cost-effective, high-quality serum-free media. • United Kingdom: A growing pharmaceutical and biotechnology sector, along with strong R&D investment and supportive government initiatives, is creating a fertile environment for market growth in the UK. • China: Government-backed research funding and heightened investments in life sciences are contributing to the rapid expansion of cell culture supply manufacturing and adoption in China. The region is emerging as a significant contributor to global revenue. Key Players Several companies are playing pivotal roles in shaping the competitive Analysis of the cell tissue culture supplies market. Key players include: • Thermo Fisher Scientific, Inc. • BD Diagnostics • EMD Millipore • Corning, Inc. • Lonza Group These firms are actively engaged in product development, strategic mergers and acquisitions, and geographic expansions. Notable developments include Thermo Fisher Scientific’s acquisition of Patheon N.V., Lonza’s acquisition of Pharmacell, and Merck KGaA’s expansion in India. Segmentation By Product • Media (Serum Containing Media, Serum-Free Media, Protein Expression Media, Stem Cell Media, Hybridoma Media, etc.) • Sera (Fetal Bovine Sera, Adult Bovine Sera, Other Animal Sera) • Reagents (Growth Factors, Supplements, Buffers & Chemicals, Cell Dissociation Reagents, Cryoprotective Agents, Others) • Vessels (Roller Bottles, Cell Stacks, Multiwell Plates, Flasks, Petri Dishes) • Accessories By Application • Biopharmaceutical Production • Diagnostics • Drug Screening & Development • Tissue Engineering & Regenerative Medicine • Stem Cell Technologies • Cancer Research By End User • Pharma and Biopharmaceutical Companies • Hospitals & Diagnostic Laboratories • Research & Academic Institutes • Others By Region • North America • Latin America • Europe • South Asia • East Asia • Oceania • Middle East & Africa Table of Contents1. Executive Summary1.1. Global Cell Tissue Culture Supplies Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2025 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. COVID-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Impact of Ukraine-Russia Conflict 2.7. Economic Overview 2.7.1. World Economic Projections 2.8. PESTLE Analysis 3. Global Cell Tissue Culture Supplies Market Outlook, 2019-2032 3.1. Global Cell Tissue Culture Supplies Market Outlook, by Product, Value (US$ Bn), 2019-2032 3.1.1. Key Highlights 3.1.1.1. Media 3.1.1.1.1. Serum Containing Media 3.1.1.1.2. Serum- Free Media 3.1.1.1.2.1. Protein Expression Media 3.1.1.1.2.2. Stem Cell Media 3.1.1.1.2.3. Hybridoma Media 3.1.1.1.2.4. Primary Cell Media 3.1.1.1.2.5. Insect Cell Media 3.1.1.1.2.6. Immunology Media 3.1.1.1.2.7. CHO Cell Culture Media 3.1.1.1.3. Protein-Free Media 3.1.1.1.4. Chemically Defined Media 3.1.1.2. Sera 3.1.1.2.1. Fetal Bovine Sera (FBS) 3.1.1.2.2. Adult Bovine Sera (ABS) 3.1.1.2.3. Other Animal Sera 3.1.1.3. Reagents 3.1.1.3.1. Growth Factors 3.1.1.3.2. Supplements 3.1.1.3.3. Buffers & Chemicals 3.1.1.3.4. Cell Dissociation Reagents 3.1.1.3.5. Cryoprotective Agents 3.1.1.3.6. Others 3.1.1.4. Vessels 3.1.1.4.1. Roller/Roux Bottles 3.1.1.4.2. Cell Stacks 3.1.1.4.3. Multiwell Plates 3.1.1.4.4. Flasks 3.1.1.4.5. Petri Dishes 3.1.1.5. Accessories 3.2. Global Cell Tissue Culture Supplies Market Outlook, by Application, Value (US$ Bn), 2019-2032 3.2.1. Key Highlights 3.2.1.1. Biopharmaceutical Production 3.2.1.2. Diagnostics 3.2.1.3. Drug Screening & Development 3.2.1.4. Tissue Engineering & Regenerative Medicine 3.2.1.5. Stem Cell Technologies 3.2.1.6. Cancer Research 3.3. Global Cell Tissue Culture Supplies Market Outlook, by End User, Value (US$ Bn), 2019-2032 3.3.1. Key Highlights 3.3.1.1. Pharma and Biopharmaceutical Companies 3.3.1.2. Hospitals & Diagnostic Laboratories 3.3.1.3. Research & Academic Institutes 3.3.1.4. Others 3.4. Global Cell Tissue Culture Supplies Market Outlook, by Region, Value (US$ Bn), 2019-2032 3.4.1. Key Highlights 3.4.1.1. North America 3.4.1.2. Europe 3.4.1.3. Asia Pacific 3.4.1.4. Latin America 3.4.1.5. Middle East & Africa 4. North America Cell Tissue Culture Supplies Market Outlook, 2019-2032 4.1. North America Cell Tissue Culture Supplies Market Outlook, by Product, Value (US$ Bn), 2019-2032 4.1.1. Key Highlights 4.1.1.1. Media 4.1.1.1.1. Serum Containing Media 4.1.1.1.2. Serum- Free Media 4.1.1.1.2.1. Protein Expression Media 4.1.1.1.2.2. Stem Cell Media 4.1.1.1.2.3. Hybridoma Media 4.1.1.1.2.4. Primary Cell Media 4.1.1.1.2.5. Insect Cell Media 4.1.1.1.2.6. Immunology Media 4.1.1.1.2.7. CHO Cell Culture Media 4.1.1.1.3. Protein-Free Media 4.1.1.1.4. Chemically Defined Media 4.1.1.2. Sera 4.1.1.2.1. Fetal Bovine Sera (FBS) 4.1.1.2.2. Adult Bovine Sera (ABS) 4.1.1.2.3. Other Animal Sera 4.1.1.3. Reagents 4.1.1.3.1. Growth Factors 4.1.1.3.2. Supplements 4.1.1.3.3. Buffers & Chemicals 4.1.1.3.4. Cell Dissociation Reagents 4.1.1.3.5. Cryoprotective Agents 4.1.1.3.6. Others 4.1.1.4. Vessels 4.1.1.4.1. Roller/Roux Bottles 4.1.1.4.2. Cell Stacks 4.1.1.4.3. Multiwell Plates 4.1.1.4.4. Flasks 4.1.1.4.5. Petri Dishes 4.1.1.5. Accessories 4.2. North America Cell Tissue Culture Supplies Market Outlook, by Application, Value (US$ Bn), 2019-2032 4.2.1. Key Highlights 4.2.1.1. Biopharmaceutical Production 4.2.1.2. Diagnostics 4.2.1.3. Drug Screening & Development 4.2.1.4. Tissue Engineering & Regenerative Medicine 4.2.1.5. Stem Cell Technologies 4.2.1.6. Cancer Research 4.3. North America Cell Tissue Culture Supplies Market Outlook, by End User, Value (US$ Bn), 2019-2032 4.3.1. Key Highlights 4.3.1.1. Pharma and Biopharmaceutical Companies 4.3.1.2. Hospitals & Diagnostic Laboratories 4.3.1.3. Research & Academic Institutes 4.3.1.4. Others 4.3.2. BPS Analysis/Market Attractiveness Analysis 4.4. North America Cell Tissue Culture Supplies Market Outlook, by Country, Value (US$ Bn), 2019-2032 4.4.1. Key Highlights 4.4.1.1. U.S. Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 4.4.1.2. U.S. Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 4.4.1.3. U.S. Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 4.4.1.4. Canada Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 4.4.1.5. Canada Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 4.4.1.6. Canada Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 4.4.2. BPS Analysis/Market Attractiveness Analysis 5. Europe Cell Tissue Culture Supplies Market Outlook, 2019-2032 5.1. Europe Cell Tissue Culture Supplies Market Outlook, by Product, Value (US$ Bn), 2019-2032 5.1.1. Key Highlights 5.1.1.1. Media 5.1.1.1.1. Serum Containing Media 5.1.1.1.2. Serum- Free Media 5.1.1.1.2.1. Protein Expression Media 5.1.1.1.2.2. Stem Cell Media 5.1.1.1.2.3. Hybridoma Media 5.1.1.1.2.4. Primary Cell Media 5.1.1.1.2.5. Insect Cell Media 5.1.1.1.2.6. Immunology Media 5.1.1.1.2.7. CHO Cell Culture Media 5.1.1.1.3. Protein-Free Media 5.1.1.1.4. Chemically Defined Media 5.1.1.2. Sera 5.1.1.2.1. Fetal Bovine Sera (FBS) 5.1.1.2.2. Adult Bovine Sera (ABS) 5.1.1.2.3. Other Animal Sera 5.1.1.3. Reagents 5.1.1.3.1. Growth Factors 5.1.1.3.2. Supplements 5.1.1.3.3. Buffers & Chemicals 5.1.1.3.4. Cell Dissociation Reagents 5.1.1.3.5. Cryoprotective Agents 5.1.1.3.6. Others 5.1.1.4. Vessels 5.1.1.4.1. Roller/Roux Bottles 5.1.1.4.2. Cell Stacks 5.1.1.4.3. Multiwell Plates 5.1.1.4.4. Flasks 5.1.1.4.5. Petri Dishes 5.1.1.5. Accessories 5.2. Europe Cell Tissue Culture Supplies Market Outlook, by Application, Value (US$ Bn), 2019-2032 5.2.1. Key Highlights 5.2.1.1. Biopharmaceutical Production 5.2.1.2. Diagnostics 5.2.1.3. Drug Screening & Development 5.2.1.4. Tissue Engineering & Regenerative Medicine 5.2.1.5. Stem Cell Technologies 5.2.1.6. Cancer Research 5.3. Europe Cell Tissue Culture Supplies Market Outlook, by End User, Value (US$ Bn), 2019-2032 5.3.1. Key Highlights 5.3.1.1. Pharma and Biopharmaceutical Companies 5.3.1.2. Hospitals & Diagnostic Laboratories 5.3.1.3. Research & Academic Institutes 5.3.1.4. Others 5.3.2. BPS Analysis/Market Attractiveness Analysis 5.4. Europe Cell Tissue Culture Supplies Market Outlook, by Country, Value (US$ Bn), 2019-2032 5.4.1. Key Highlights 5.4.1.1. Germany Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 5.4.1.2. Germany Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 5.4.1.3. Germany Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 5.4.1.4. U.K. Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 5.4.1.5. U.K. Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 5.4.1.6. U.K. Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 5.4.1.7. France Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 5.4.1.8. France Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 5.4.1.9. France Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 5.4.1.10. Italy Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 5.4.1.11. Italy Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 5.4.1.12. Italy Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 5.4.1.13. Turkey Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 5.4.1.14. Turkey Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 5.4.1.15. Turkey Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 5.4.1.16. Russia Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 5.4.1.17. Russia Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 5.4.1.18. Russia Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 5.4.1.19. Rest of Europe Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 5.4.1.20. Rest of Europe Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 5.4.1.21. Rest of Europe Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 5.4.2. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Cell Tissue Culture Supplies Market Outlook, 2019-2032 6.1. Asia Pacific Cell Tissue Culture Supplies Market Outlook, by Product, Value (US$ Bn), 2019-2032 6.1.1. Key Highlights 6.1.1.1. Media 6.1.1.1.1. Serum Containing Media 6.1.1.1.2. Serum- Free Media 6.1.1.1.2.1. Protein Expression Media 6.1.1.1.2.2. Stem Cell Media 6.1.1.1.2.3. Hybridoma Media 6.1.1.1.2.4. Primary Cell Media 6.1.1.1.2.5. Insect Cell Media 6.1.1.1.2.6. Immunology Media 6.1.1.1.2.7. CHO Cell Culture Media 6.1.1.1.3. Protein-Free Media 6.1.1.1.4. Chemically Defined Media 6.1.1.2. Sera 6.1.1.2.1. Fetal Bovine Sera (FBS) 6.1.1.2.2. Adult Bovine Sera (ABS) 6.1.1.2.3. Other Animal Sera 6.1.1.3. Reagents 6.1.1.3.1. Growth Factors 6.1.1.3.2. Supplements 6.1.1.3.3. Buffers & Chemicals 6.1.1.3.4. Cell Dissociation Reagents 6.1.1.3.5. Cryoprotective Agents 6.1.1.3.6. Others 6.1.1.4. Vessels 6.1.1.4.1. Roller/Roux Bottles 6.1.1.4.2. Cell Stacks 6.1.1.4.3. Multiwell Plates 6.1.1.4.4. Flasks 6.1.1.4.5. Petri Dishes 6.1.1.5. Accessories 6.2. Asia Pacific Cell Tissue Culture Supplies Market Outlook, by Application, Value (US$ Bn), 2019-2032 6.2.1. Key Highlights 6.2.1.1. Biopharmaceutical Production 6.2.1.2. Diagnostics 6.2.1.3. Drug Screening & Development 6.2.1.4. Tissue Engineering & Regenerative Medicine 6.2.1.5. Stem Cell Technologies 6.2.1.6. Cancer Research 6.3. Asia Pacific Cell Tissue Culture Supplies Market Outlook, by End User, Value (US$ Bn), 2019-2032 6.3.1. Key Highlights 6.3.1.1. Pharma and Biopharmaceutical Companies 6.3.1.2. Hospitals & Diagnostic Laboratories 6.3.1.3. Research & Academic Institutes 6.3.1.4. Others 6.3.2. BPS Analysis/Market Attractiveness Analysis 6.4. Asia Pacific Cell Tissue Culture Supplies Market Outlook, by Country, Value (US$ Bn), 2019-2032 6.4.1. Key Highlights 6.4.1.1. China Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 6.4.1.2. China Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 6.4.1.3. China Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 6.4.1.4. Japan Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 6.4.1.5. Japan Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 6.4.1.6. Japan Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 6.4.1.7. South Korea Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 6.4.1.8. South Korea Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 6.4.1.9. South Korea Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 6.4.1.10. India Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 6.4.1.11. India Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 6.4.1.12. India Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 6.4.1.13. Southeast Asia Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 6.4.1.14. Southeast Asia Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 6.4.1.15. Southeast Asia Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 6.4.1.16. Rest of Asia Pacific Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 6.4.1.17. Rest of Asia Pacific Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 6.4.1.18. Rest of Asia Pacific Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 6.4.2. BPS Analysis/Market Attractiveness Analysis 7. Latin America Cell Tissue Culture Supplies Market Outlook, 2019-2032 7.1. Latin America Cell Tissue Culture Supplies Market Outlook, by Product, Value (US$ Bn), 2019-2032 7.1.1. Key Highlights 7.1.1.1. Media 7.1.1.1.1. Serum Containing Media 7.1.1.1.2. Serum- Free Media 7.1.1.1.2.1. Protein Expression Media 7.1.1.1.2.2. Stem Cell Media 7.1.1.1.2.3. Hybridoma Media 7.1.1.1.2.4. Primary Cell Media 7.1.1.1.2.5. Insect Cell Media 7.1.1.1.2.6. Immunology Media 7.1.1.1.2.7. CHO Cell Culture Media 7.1.1.1.3. Protein-Free Media 7.1.1.1.4. Chemically Defined Media 7.1.1.2. Sera 7.1.1.2.1. Fetal Bovine Sera (FBS) 7.1.1.2.2. Adult Bovine Sera (ABS) 7.1.1.2.3. Other Animal Sera 7.1.1.3. Reagents 7.1.1.3.1. Growth Factors 7.1.1.3.2. Supplements 7.1.1.3.3. Buffers & Chemicals 7.1.1.3.4. Cell Dissociation Reagents 7.1.1.3.5. Cryoprotective Agents 7.1.1.3.6. Others 7.1.1.4. Vessels 7.1.1.4.1. Roller/Roux Bottles 7.1.1.4.2. Cell Stacks 7.1.1.4.3. Multiwell Plates 7.1.1.4.4. Flasks 7.1.1.4.5. Petri Dishes 7.1.1.5. Accessories 7.2. Latin America Cell Tissue Culture Supplies Market Outlook, by Application, Value (US$ Bn), 2019-2032 7.2.1.1. Biopharmaceutical Production 7.2.1.2. Diagnostics 7.2.1.3. Drug Screening & Development 7.2.1.4. Tissue Engineering & Regenerative Medicine 7.2.1.5. Stem Cell Technologies 7.2.1.6. Cancer Research 7.3. Latin America Cell Tissue Culture Supplies Market Outlook, by End User, Value (US$ Bn), 2019-2032 7.3.1. Key Highlights 7.3.1.1. Pharma and Biopharmaceutical Companies 7.3.1.2. Hospitals & Diagnostic Laboratories 7.3.1.3. Research & Academic Institutes 7.3.1.4. Others 7.3.2. BPS Analysis/Market Attractiveness Analysis 7.4. Latin America Cell Tissue Culture Supplies Market Outlook, by Country, Value (US$ Bn), 2019-2032 7.4.1. Key Highlights 7.4.1.1. Brazil Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 7.4.1.2. Brazil Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 7.4.1.3. Brazil Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 7.4.1.4. Mexico Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 7.4.1.5. Mexico Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 7.4.1.6. Mexico Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 7.4.1.7. Argentina Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 7.4.1.8. Argentina Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 7.4.1.9. Argentina Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 7.4.1.10. Rest of Latin America Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 7.4.1.11. Rest of Latin America Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 7.4.1.12. Rest of Latin America Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 7.4.2. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Cell Tissue Culture Supplies Market Outlook, 2019-2032 8.1. Middle East & Africa Cell Tissue Culture Supplies Market Outlook, by Product, Value (US$ Bn), 2019-2032 8.1.1. Key Highlights 8.1.1.1. Media 8.1.1.1.1. Serum Containing Media 8.1.1.1.2. Serum- Free Media 8.1.1.1.2.1. Protein Expression Media 8.1.1.1.2.2. Stem Cell Media 8.1.1.1.2.3. Hybridoma Media 8.1.1.1.2.4. Primary Cell Media 8.1.1.1.2.5. Insect Cell Media 8.1.1.1.2.6. Immunology Media 8.1.1.1.2.7. CHO Cell Culture Media 8.1.1.1.3. Protein-Free Media 8.1.1.1.4. Chemically Defined Media 8.1.1.2. Sera 8.1.1.2.1. Fetal Bovine Sera (FBS) 8.1.1.2.2. Adult Bovine Sera (ABS) 8.1.1.2.3. Other Animal Sera 8.1.1.3. Reagents 8.1.1.3.1. Growth Factors 8.1.1.3.2. Supplements 8.1.1.3.3. Buffers & Chemicals 8.1.1.3.4. Cell Dissociation Reagents 8.1.1.3.5. Cryoprotective Agents 8.1.1.3.6. Others 8.1.1.4. Vessels 8.1.1.4.1. Roller/Roux Bottles 8.1.1.4.2. Cell Stacks 8.1.1.4.3. Multiwell Plates 8.1.1.4.4. Flasks 8.1.1.4.5. Petri Dishes 8.1.1.5. Accessories 8.2. Middle East & Africa Cell Tissue Culture Supplies Market Outlook, by Application, Value (US$ Bn), 2019-2032 8.2.1. Key Highlights 8.2.1.1. Biopharmaceutical Production 8.2.1.2. Diagnostics 8.2.1.3. Drug Screening & Development 8.2.1.4. Tissue Engineering & Regenerative Medicine 8.2.1.5. Stem Cell Technologies 8.2.1.6. Cancer Research 8.3. Middle East & Africa Cell Tissue Culture Supplies Market Outlook, by End User, Value (US$ Bn), 2019-2032 8.3.1. Key Highlights 8.3.1.1. Pharma and Biopharmaceutical Companies 8.3.1.2. Hospitals & Diagnostic Laboratories 8.3.1.3. Research & Academic Institutes 8.3.1.4. Others 8.3.2. BPS Analysis/Market Attractiveness Analysis 8.4. Middle East & Africa Cell Tissue Culture Supplies Market Outlook, by Country, Value (US$ Bn), 2019-2032 8.4.1. Key Highlights 8.4.1.1. GCC Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 8.4.1.2. GCC Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 8.4.1.3. GCC Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 8.4.1.4. South Africa Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 8.4.1.5. South Africa Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 8.4.1.6. South Africa Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 8.4.1.7. Egypt Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 8.4.1.8. Egypt Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 8.4.1.9. Egypt Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 8.4.1.10. Nigeria Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 8.4.1.11. Nigeria Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 8.4.1.12. Nigeria Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 8.4.1.13. Rest of Middle East & Africa Cell Tissue Culture Supplies Market by Product, Value (US$ Bn), 2019-2032 8.4.1.14. Rest of Middle East & Africa Cell Tissue Culture Supplies Market by Application, Value (US$ Bn), 2019-2032 8.4.1.15. Rest of Middle East & Africa Cell Tissue Culture Supplies Market by End User, Value (US$ Bn), 2019-2032 8.4.2. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. By Segment 3 vs by Application Heat map 9.2. Manufacturer vs by Application Heatmap 9.3. Company Market Share Analysis, 2025 9.4. Competitive Dashboard 9.5. Company Profiles 9.5.1. Thermo Fisher Scientific. 9.5.1.1. Company Overview 9.5.1.2. Product Portfolio 9.5.1.3. Financial Overview 9.5.1.4. Business Strategies and Development 9.5.2. BD Diagnostics 9.5.2.1. Company Overview 9.5.2.2. Product Portfolio 9.5.2.3. Financial Overview 9.5.2.4. Business Strategies and Development 9.5.3. EMD Millipore 9.5.3.1. Company Overview 9.5.3.2. Product Portfolio 9.5.3.3. Financial Overview 9.5.3.4. Business Strategies and Development 9.5.4. Corning 9.5.4.1. Company Overview 9.5.4.2. Product Portfolio 9.5.4.3. Financial Overview 9.5.4.4. Business Strategies and Development 9.5.5. Lonza Group 9.5.5.1. Company Overview 9.5.5.2. Product Portfolio 9.5.5.3. Financial Overview 9.5.5.4. Business Strategies and Development 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療IT)の最新刊レポート
Fairfield Market Research社の ヘルスケアIT分野 での最新刊レポート
本レポートと同じKEY WORD(tissue)の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|